Daily Archives: December 1, 2021
Complete countrywide mortality in COVID patients receiving ECMO in Germany throughout the first three waves of the pandemic.
1 Dec, 2021 | 09:52h | UTC
WHO advice for international traffic in relation to the SARS-CoV-2 Omicron variant (B.1.1.529).
1 Dec, 2021 | 10:02h | UTCCommentary: Over-60s, vulnerable should postpone travel due to Omicron: WHO – MedicalXpress
See also the latest articles on the subject:
WHO pleads for ‘rational’ Omicron response – MedicalXpress
Omicron: WHO warns of ‘high infection risk’ around globe – BBC
Video: Why Omicron is the most worrying Covid variant yet – video explainer – The Guardian
Doctors hope Omicron causes milder cases of Covid — but it’s still too early to say – STAT
Doctor: Many South Africans ill in surge have mild symptoms – Associated Press
New Findings Show the Omicron Variant Spread Widely At a Faster Pace Than Initially Thought – TIME
Why some researchers think the omicron variant could be the most infectious one yet – NPR
Omicron Covid variant ‘present in Europe at least 10 days ago’ – The Guardian
Netherlands says Omicron variant was already in country earlier than previously thought – CNN
Netherlands detections hint at earlier Omicron spread – CIDRAP
Epidemiologist awaits clearer picture on omicron – Harvard University
Pfizer research head envisions a sprint to develop Omicron vaccine, if it’s needed – STAT
Moderna boss predicts current vaccines may be less effective against Omicron – The Guardian
Travel restrictions by country following the Omicron variant outbreak – CNN
FDA panel narrowly recommends authorization of first antiviral pill to treat COVID.
1 Dec, 2021 | 09:56h | UTCFDA panel narrowly recommends authorization of first antiviral pill to treat COVID – STAT
See also: An FDA panel supports Merck COVID drug in mixed vote – NPR
Related:
8 lingering questions about the new Covid pills from Merck and Pfizer.
The U.K. approves Merck’s COVID-19 antiviral pill, calling it a world first.
Merck to allow other nations to produce new COVID-19 antiviral.
Video: Merck’s Covid pill could transform treatment. Here’s how it works.
How antiviral pill Molnupiravir shot ahead in the COVID drug hunt.
What we know — and don’t know — about Merck’s new Covid-19 pill.
Merck’s Covid-19 pill is great news but may not be a game-changer.
Video | A Pill For COVID? A Doctor Explains Molnupiravir.
Ending the COVID-19 Pandemic Hinges on Trust: Science alone won’t pull us out of the pandemic.
1 Dec, 2021 | 09:47h | UTCEnding the COVID-19 Pandemic Hinges on Trust – Think Global Health
Commentary on Twitter
Despite the availability of effective vaccines, deaths from #COVID in 2021 are two-thirds greater than the # of COVID-related deaths in 2020. @TomBollyky & @IHME_UW's Chris Troeger say trust—and the lack of it—has played a crucial role in the pandemic.https://t.co/8NiItD1wdc
— Think Global Health (@ThinkGlobalHlth) November 30, 2021
Using wearable data, a real-time alerting system can be used for the early detection of Covid-19 and other stress events.
1 Dec, 2021 | 09:59h | UTCReal-time alerting system for COVID-19 and other stress events using wearable data – Nature Medicine
Commentary: Scientists develop a smartwatch-based device for early detection of COVID-19 – News Medical
Commentary on Twitter
A study in @NatureMedicine shows that a smartwatch-based alerting system was able to detect pre-symptomatic and asymptomatic SARS-CoV-2 infection in a high percentage of cases. https://t.co/tquzpYa4pV pic.twitter.com/VIq3phKZ7J
— Nature Portfolio (@NaturePortfolio) November 30, 2021
Another randomized trial showed convalescent plasma does not benefit patients hospitalized with Covid-19.
1 Dec, 2021 | 09:49h | UTCRelated:
M-A: Convalescent plasma does not reduce mortality in COVID-19.
M-A: Convalescent plasma is safe but does not improve outcomes in the treatment of COVID-19.
RECOVERY Trial: No benefit from convalescent plasma in patients admitted to hospital with COVID-19.
Commentary on Twitter
The TSUNAMI RCT showed that high-titer convalescent plasma (CP) did not reduce the risk of severe respiratory failure or death in hospitalized patients with #COVID19 pneumonia. https://t.co/4q0S2AtfMj
— JAMA Network Open (@JAMANetworkOpen) November 29, 2021
Guidelines developed under pressure. The case of the COVID-19 low-quality “rapid” guidelines and potential solutions.
1 Dec, 2021 | 08:54h | UTC
Cohort study: Allergic conditions linked to lower COVID-19 infection risk.
1 Dec, 2021 | 08:52h | UTCNews Release: Allergic conditions linked to lower COVID-19 infection risk – BMJ
Original Study: Risk factors for developing COVID-19: a population-based longitudinal study (COVIDENCE UK) – Thorax
NICE Guideline | Tobacco: preventing uptake, promoting quitting, and treating dependence.
1 Dec, 2021 | 08:50h | UTC
RCT: Intravenous or intraosseous calcium does not improve the return of spontaneous circulation in adults with out-of-hospital cardiac arrest.
1 Dec, 2021 | 08:46h | UTC
Commentary on Twitter
RCT of IV/IO calcium in OHCA stopped early by safety committee due to concerns about increased mortality in those who received calcium.
Great prehospital research and good to see trial safety monitoring working.https://t.co/wFZEjOMyMO@JAMA_current @CritCareReviews pic.twitter.com/gdi7yfhxZo
— David Anderson (@expensivecare) November 30, 2021
AAP Clinical Report: Promoting the participation of children and adolescents with disabilities in sports, recreation, and physical activity.
1 Dec, 2021 | 08:48h | UTC
Commentary on Twitter
Children with disabilities benefit from physical activity of all kinds. Now is the time to focus on the inclusion of children based on their strengths and abilities, according to a clinical report published by AAP in Pediatrics this week.https://t.co/zlL9aOGwUU
— American Academy of Pediatrics (@AmerAcadPeds) November 30, 2021
M-A: Efficacy of non-invasive and invasive respiratory management strategies in adult patients with acute hypoxemic respiratory failure.
1 Dec, 2021 | 08:44h | UTC
Global estimates of viral suppression in 31 countries shows too many people with HIV fail to achieve durable viral suppression.
1 Dec, 2021 | 08:41h | UTCNews Release: Too many people with HIV fail to achieve durable viral suppression – NIH News Releases
Original Study: Global estimates of viral suppression in children and adolescents and adults on antiretroviral therapy adjusted for missing viral load measurements: a multiregional, retrospective cohort study in 31 countries – The Lancet HIV (link to abstract – $ for full-text)
Review: Ethical advice in pediatric care.
1 Dec, 2021 | 08:42h | UTCEthical advice in paediatric care – Archives of Disease in Childhood
Integrative oncology: Addressing the global challenges of cancer prevention and treatment.
1 Dec, 2021 | 08:34h | UTCCommentary: Addressing the Global Challenges of Cancer Prevention and Treatment – The ASCO Post
Review: Current treatment and future directions in the management of anal cancer.
1 Dec, 2021 | 08:38h | UTC
Systematic Review: Late (after 6 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
1 Dec, 2021 | 08:32h | UTC
CT imaging of peritoneal carcinomatosis with surgical correlation: a pictorial review.
1 Dec, 2021 | 08:30h | UTC
Systematic Review: Early (started within six days) systemic postnatal corticosteroids for preventing bronchopulmonary dysplasia in preterm infants.
1 Dec, 2021 | 08:33h | UTCOriginal Study: Early (< 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants – Cochrane Library
Commentary on Twitter
Early (started within six days) systemic #postnatal #corticosteroids for preventing bronchopulmonary dysplasia in #preterm #infants https://t.co/Ui6xZPoTj1 Updated @CochraneNeonate systematic review looks at evidence from 32 studies with 4395 infants.
— The Cochrane Library (@CochraneLibrary) October 29, 2021